Skip to content

Author

Yi Luo

We have 1 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Jul 2026

SLFN11 binds DDX1 to counteract human mesenchymal stem/stromal cell senescence through inhibition of mTOR/eIF4E signaling pathway activation.

A non-canonical role for SLFN11 safeguarding MSCs from senescence via the DDX1/mTOR/eIF4E axis is delineated and SLFN11-overexpressing MSCs constitute a promising and safe cell therapy source, characterized by preserved pluripotency and augmented therapeutic efficacy.

Xin-Xin Zhu, Yi Luo, Jin-Yan Xu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.